Berwyn, PA – April 2019 – In recognition of April as the federally designated observation of National Cancer Control Month, AscellaHealth (Ascella), a national Pharmacy Benefit Management (PBM) serving commercial, Medicare and Medicaid segments, urges patients, families and communities to help raise awareness of prevention and screening as the best defenses against cancer and emphasize the importance of recognizing advances that progress toward effective cancer control. Ascella points to the complexity and collaboration required in the management of cancer, highlighting the role of its clinical and educational programs to assist members with their prescribed therapy – beginning on day one: helping with high deductible/co-insurance costs by utilizing financial assistance programs and partnering with physicians and pharmacists throughout the member’s course of treatment.
“Treating a cancer patient requires a strategic approach to specialty pharmacy that is designed to improve outcomes and care coordination for health plan members,” says Dea Belazi, president and CEO, AscellaHealth. “Our high-touch model includes clinical interventions, adherence counseling, psychosocial assessment, integrated nursing staff, refill reminders and delivery coordination as part of Ascella’s innovative specialty pharmacy strategy.”
In 2019, there will be approximately 140,690 cancer cases diagnosed and about 103,250 cancer deaths among the nation’s oldest individuals.
Ascella’s program is available on a standalone basis, or as part of a full-service pharmacy benefit management option that includes specialty drug management, formulary management services/rebates, competitive pricing and innovative discounting, drug utilization review, case management services/therapy management, clinical review/prior authorization, pharmacy and therapeutic management committee, flexible claims adjudication system, drug information and news reporting.
“This April we are more committed than ever to helping health plan members battle cancer, striving to make a difference in their lives while maximizing benefit plans,” Belazi adds. “By reducing costs, including discounted prices as part of the exceptional value we provide, our approach to specialty drugs can be a vital factor in cancer treatment.”
AscellaHealth, a national PBM serving commercial, Medicare and Medicaid segments offers high quality prescription drug management services along with other customizable services, such as carved-out specialty pharmacy services and cost-savings discount programs through its unique and proprietary service that extends discounts on prescription medications to customers more than any other PBM in the industry. Visit www.ascellahealth.com.